See more : Jiangsu Huaxicun Co.,Ltd. (000936.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of European Medical Solutions (ALEMS.BR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of European Medical Solutions, a leading company in the Biotechnology industry within the Healthcare sector.
- More Acquisitions Plc (TMOR.L) Income Statement Analysis – Financial Results
- Viemed Healthcare, Inc. (VMD.TO) Income Statement Analysis – Financial Results
- Skyline Investments Inc. (SKLN.TA) Income Statement Analysis – Financial Results
- Argus Capital Corp. (ARGU) Income Statement Analysis – Financial Results
- MSA Safety Incorporated (MNESP) Income Statement Analysis – Financial Results
European Medical Solutions (ALEMS.BR)
About European Medical Solutions
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. DMS Imaging SA was founded in 1979 and is headquartered in Ixelles, Belgium. European Medical Solutions operates as a subsidiary of Diagnostic Medical Systems S.A.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.56M | 37.06M | 38.02M | 358.94K | 1.06M | 570.75K | 604.00K | 1.68M | 4.00K | 5.00K | 7.00K |
| Cost of Revenue | 27.05M | 23.28M | 24.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00K | 0.00 | 3.00K |
| Gross Profit | 13.51M | 13.78M | 13.80M | 358.94K | 1.06M | 570.75K | 604.00K | 1.68M | 1.00K | 5.00K | 10.00K |
| Gross Profit Ratio | 33.31% | 37.18% | 36.31% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 25.00% | 100.00% | 142.86% |
| Research & Development | 2.00K | 40.00K | 0.00 | 53.00K | 13.91M | 10.86M | 10.90M | 12.12M | 6.69M | 3.54M | 1.67M |
| General & Administrative | 295.00K | 420.00K | 423.00K | 932.00K | 2.91M | 2.37M | 1.68M | 1.76M | 916.00K | 754.00K | 616.00K |
| Selling & Marketing | 225.00K | 227.00K | 10.86M | 154.00K | 595.00K | 540.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 520.00K | 11.48M | 11.28M | 1.09M | 3.50M | 2.91M | 2.00M | 2.07M | 1.10M | 852.00K | 699.00K |
| Other Expenses | 13.13M | 0.00 | 0.00 | 11.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 13.65M | 19.13M | 13.85M | 1.24M | 17.03M | 14.89M | 12.59M | 13.97M | 7.65M | 4.33M | 2.31M |
| Cost & Expenses | 40.70M | 42.41M | 38.06M | 1.24M | 17.03M | 14.89M | 12.59M | 13.97M | 7.65M | 4.33M | 2.31M |
| Interest Income | 85.00K | 226.00K | 200.00K | 476.00K | 306.00K | 0.00 | 6.00K | 54.00K | 71.00K | 106.00K | 18.00K |
| Interest Expense | 432.00K | 237.00K | 200.00K | 503.00K | 0.00 | 0.00 | 0.00 | 0.00 | 102.00K | 112.00K | 31.00K |
| Depreciation & Amortization | 2.20M | 4.09M | 1.93M | 117.00K | 296.00K | 253.00K | 205.00K | 141.00K | 80.00K | 20.00K | 22.00K |
| EBITDA | 2.02M | -1.25M | 2.05M | -514.66K | 0.00 | -12.51M | -11.77M | -12.14M | -7.53M | -4.30M | -2.27M |
| EBITDA Ratio | 4.98% | 6.26% | 5.39% | -143.38% | -1,470.17% | -2,192.55% | -1,948.68% | -721.09% | -189,000.00% | -85,960.00% | -32,514.29% |
| Operating Income | -135.00K | -1.77M | 118.00K | -631.66K | -15.95M | -12.77M | -11.98M | -12.28M | -7.64M | -4.32M | -2.30M |
| Operating Income Ratio | -0.33% | -4.79% | 0.31% | -175.98% | -1,497.97% | -2,236.88% | -1,982.62% | -729.46% | -191,000.00% | -86,360.00% | -32,828.57% |
| Total Other Income/Expenses | -575.00K | -3.81M | -271.00K | -730.34K | 295.00K | -1.56M | -9.00K | -60.00K | -75.00K | -111.00K | -21.00K |
| Income Before Tax | -710.00K | -5.58M | -242.00K | -1.36M | -15.66M | -14.32M | -11.98M | -12.34M | -7.72M | -4.43M | -2.32M |
| Income Before Tax Ratio | -1.75% | -15.07% | -0.64% | -379.45% | -1,470.27% | -2,509.68% | -1,984.11% | -733.03% | -192,875.00% | -88,580.00% | -33,128.57% |
| Income Tax Expense | 2.00K | 1.00K | 1.00K | 0.00 | 0.00 | 3.00K | 2.00K | 1.00K | 0.00 | 0.00 | 0.00 |
| Net Income | -709.00K | -5.58M | -241.00K | -1.36M | -15.66M | -14.32M | -11.99M | -12.34M | -7.72M | -4.43M | -2.32M |
| Net Income Ratio | -1.75% | -15.05% | -0.63% | -379.45% | -1,470.27% | -2,509.15% | -1,984.44% | -733.09% | -192,875.00% | -88,580.00% | -33,128.57% |
| EPS | 0.00 | 0.00 | -0.01 | -0.06 | -0.77 | -0.86 | -0.94 | -1.10 | -0.91 | -0.76 | -0.40 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.06 | -0.77 | -0.86 | -0.94 | -1.10 | -0.91 | -0.76 | -0.40 |
| Weighted Avg Shares Out | 1.42B | 1.49B | 24.10M | 21.89M | 20.35M | 16.72M | 12.81M | 11.22M | 8.50M | 5.85M | 5.78M |
| Weighted Avg Shares Out (Dil) | 1.49B | 1.49B | 24.10M | 21.89M | 20.35M | 16.72M | 12.81M | 11.22M | 8.50M | 5.85M | 5.78M |
Source: https://incomestatements.info
Category: Stock Reports